PALLADIEM, LLC

Position in NVS — Novartis AG

CIK 1629271 BRYN MAWR, PA

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$312,813

-$20,334 QoQ

Shares Held

1,996

-8.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.88%

of 13F equity value

Holder Rank

#1,109

of 1,603 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PALLADIEM, LLC holds $985,691 across 8 Drug Manufacturers - General names. NVS ranks #2 (31.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	328	$393,413
2	NVS	Novartis AG This page	1,996	$312,813
3	AZN	Astrazeneca PLC	1,416	$268,501
4	JNJ	Johnson & Johnson	19	$4,825
5	GILD	Gilead Sciences, Inc.	19	$2,400
6	AMGN	Amgen Inc	4	$1,448
7	MRK	Merck & Co., Inc.	10	$1,285
8	ABBV	AbbVie Inc.	4	$1,006

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$312,813	1,996	-8.5%	Shares	Sole	2026-08-13
2026-03-31	$333,147	2,181	+0.5%	Shares	Sole	2026-05-06
2025-12-31	$299,177	2,170	-19.9%	Shares	Sole	2026-02-11
2023-09-30	$275,836	2,708	+7.3%	Shares	Sole	2023-12-08
2023-06-30	$254,595	2,523	0.0%	Shares	Sole	2023-12-08
2023-03-31	$232,116	2,523	0.0%	Shares	Sole	2023-05-04
2022-12-31	$228,886	2,523	-1.2%	Shares	Sole	2023-02-02
2022-06-30	$215,805	2,553	-8.6%	Shares	Sole	2022-07-26
2022-03-31	$245,085	2,793	0.0%	Shares	Sole	2022-04-22
2021-12-31	$244,303	2,793	0.0%	Shares	Sole	2022-02-11
2021-09-30	$228,411	2,793	0.0%	Shares	Sole	2021-11-10
2021-06-30	$254,833	2,793	0.0%	Shares	Sole	2021-07-14
2021-03-31	$238,745	2,793	-0.1%	Shares	Sole	2021-05-12
2020-12-31	$264,120	2,797	—	Shares	Sole	2021-01-14
No filing history on record for this holder in this stock.